What are the payment terms?

We accept T/T, LC, and D/P as terms of payment.

Ciprofloxacin Oral Tablets 500mg - Trusted Infection Relief

Name: Ciprofloxacin Oral Tablets 500mg - Trusted Infection Relief
Brand: Anhui Medipharm Co., Ltd.
SKU: 776039345

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$0.22-0.32

50,000 box

Product profile

Customization

Available

Type

GMP

Pharmaceutical Technology

Chemical Synthesis

Model NO.

AMC12014-03

Specificate

500mg

Registration

Available

OEM

Available

Transport Package

500mg, 1X10's/Box

Trademark

Medipharm, OEM

Origin

China

HS Code

30042090

Production Capacity

100000ctns Per Month

Key features

GMP Certified Production: Manufactured under strict GMP standards ensuring high quality and safety.

ISO Management Certified: Holds ISO9001:2015, ISO45001:2018, and ISO14001 certifications.

Full Customization Available: Offers customization from designs, samples, and full customization options.

14 Years Export Experience: Over a decade of international trade experience with global reach.

High Repeat Buyer Rate: 80% to 100% repeat buyer rate indicating high customer satisfaction.

Flexible Payment Terms: Accepts T/T, LC, and D/P for convenient international transactions.

Global Market Presence: Exports to South America, Southeast Asia, Middle East, Africa, and South Asia.

Professional R&D Team: Equipped with 5 dedicated R&D engineers for product innovation.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.63h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.